Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes

Abstract Background Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in dev...

Full description

Bibliographic Details
Published in:Cardiovascular Diabetology
Main Authors: Zhe Huang, Lucija Klaric, Justina Krasauskaite, Stela McLachlan, Mark W. J. Strachan, James F. Wilson, Jackie F. Price
Format: Article
Language:English
Published: BMC 2022-04-01
Subjects:
Atherosclerosis
Cardiovascular diseases
Glycolysis
Lactate
Lipidomics
Metabolomics
Online Access:https://doi.org/10.1186/s12933-022-01493-w

Internet

https://doi.org/10.1186/s12933-022-01493-w

Similar Items